Pfizer Inc
(PFE-NYSE)
DRUGS - Drug Manufacturers - Major
Stock report updated on 01/20/2012
- PFE is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- Volatility is forecast to fall over the next month.
- Price broke above prior resistance level - a short-term bullish signal.
| Closing price: |
$21.90 |
| Support price level: |
$20.45 |
| Resistance price level: |
N/A |
| Relative strength index (14-day RSI): |
55.4 |
| Beta: |
0.68 |
52-Week Range
| Low |
High |
Price as % of Range |
| $16.66 |
$21.99 |
98.5% |
Moving Averages
| 200 day |
50 day |
20 day |
10 day |
| $19.80 |
$20.69 |
$21.79 |
$21.87 |
Volatility (annualized std. dev.)
Historical
(5 year) |
Last month |
Current estimate |
Next month forecast |
| 27.7% |
21.3% |
16.3% |
21.2% |
Value at Risk
There is an estimated 5% probability that the stock price of Pfizer Inc will fall by more than:
- 4.4% in the next week.
- 12.0% in the next month.
- 47.9% in the next year.
Company News for Pfizer Inc
Google Finance |
MSN Money |
Reuters
Reports for Other Stocks
